Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Nanosonics Limited ( (AU:NAN) ) just unveiled an announcement.
Nanosonics Limited has announced an on-market buy-back of its ordinary fully paid securities, as indicated by the ASX security code NAN. This strategic financial move is likely aimed at optimizing the company’s capital structure and could have implications for shareholder value and market perception.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.00 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited operates in the medical technology industry, specializing in infection prevention solutions. The company is known for its innovative products, including the trophon® EPR, which is a leading ultrasound probe disinfection system, and it focuses on enhancing patient safety and reducing hospital-acquired infections.
Average Trading Volume: 651,130
Technical Sentiment Signal: Buy
Current Market Cap: A$1.3B
For a thorough assessment of NAN stock, go to TipRanks’ Stock Analysis page.